Latest Articles
- Tonsillectomy in adults: A paucity of data
We need to differentiate recurrent viral pharyngitis from streptococcal tonsillitis before recommending surgery.
- Acne vulgaris: One treatment does not fit all
With a variety of topical and oral agents available, the choice of therapy can range from simple and straightforward to intense and complex.
- The case for clinical trials of noninvasive coronary imaging tests
IVUS, CT, and MRI show promise, but new tests, like new therapies, must undergo clinical trials.
When does an adult need a tonsillectomy?Tonsillectomy may improve quality of life, but hard data are lacking.
Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?The evidence so far indicates that neither drug can be recommended for this indication in this situation.
- Using C-reactive protein to assess cardiovascular disease risk
CRP is now a recognized cardiac test. But who should he tested?
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosisWe have an important new drug for osteoporosis. Now who should get it? And who will pay for it?
- The promise of molecular biology: Efficacy, safety, wallet depletion
Molecular biology is entering its second wave, with effective but expensive treatments. Recombinant human parathyroid hormone (PTH) is a case in point.